Apollo Endosurgery Upgraded To Overweight From Neutral At Piper Sandler
November 30, 2020 at 05:12 AM EST
Piper Sandler analyst Adam Maeder upgraded Apollo Endosurgery to Overweight from Neutral with a price target of $5, up from $2.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|